Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, H.
Right arrow Articles by Jo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, H.
Right arrow Articles by Jo, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 48, 32304-32311, November 27, 1998


Plasma Membrane Cholesterol Is a Key Molecule in Shear Stress-dependent Activation of Extracellular Signal-regulated Kinase*

Heonyong ParkDagger , Young-Mi GoDagger , Patricia L. St. John§, Matthew C. MalandDagger , Michael P. Lisanti, Dale R. Abrahamson§, and Hanjoong JoDagger parallel

From the Departments of Dagger  Pathology and § Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294 and the  Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Shear stress, the dragging force generated by fluid flow, differentially activates extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) in bovine aortic endothelial cells (BAEC) (Jo, H., Sipos, K., Go, Y. M., Law, R., Rong, J., and McDonald, J. M. (1997) J. Biol. Chem. 272, 1395-1401). Here, we examine whether cholesterol-enriched compartments in the plasma membrane are responsible for such differential regulation. Pretreatment of BAEC with a cholesterol-binding antibiotic, filipin, did not inhibit shear-dependent activation of JNK. In contrast, filipin and other membrane-permeable cholesterol-binding agents (digitonin and nystatin), but not the lipid-binding agent xylazine, inhibited shear-dependent activation of ERK. The effect of cholesterol-binding drugs did not appear to be due to membrane permeabilization, since treatment of BAEC with a detergent, Triton X-100 which also permeabilizes membranes, did not inhibit shear-dependent activation of ERK. Furthermore, shear-dependent activation of ERK, but not JNK, was inhibited by cyclodextrin, a membrane-impermeable cholesterol-binding agent, which removes cell-surface cholesterol. Moreover, the effects of cyclodextrin were prevented by adding cholesterol during the incubation. These results indicate that cholesterol or cholesterol-sensitive compartments in the plasma membrane play a selective and essential role in activation of ERK, but not JNK, by shear stress. Although exposure to shear stress (1 h) increased the number of caveolae by 3-fold, treatment with filipin had no effect in either control or shear-exposed cells suggesting that caveolae density per se is not a crucial determinant in shear-dependent ERK activation. In summary, the current study suggests that cholesterol-sensitive microdomains in the plasma membrane, such as caveolae-like domains, play a critical role in differential activation of ERK and JNK by shear stress.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Vascular endothelial cells recognize shear stress by unknown mechanosensing system(s) that respond both acutely and chronically to flow by producing autocrine and paracrine factors (1). Through these endothelial responses, shear stress controls vascular tone, vessel wall remodeling, binding of blood cells to endothelium, and hemostasis (1). Shear stress selectively and differentially regulates expression of many genes that are important in the pathophysiology of vessel wall function (2-10). Furthermore, a conserved cis-acting shear stress response element has been identified in many shear-sensitive genes including platelet-derived growth factor-B, intercellular adhesion molecule-1, tissue plasminogen activator, and transforming growth factor beta -1, suggesting its broad implication in shear-dependent regulation of gene expressions (6, 8). Shear stress also transiently activates nuclear factor-kappa B, immediate early response genes, and transcription factors that are likely to be involved in the regulation of shear-dependent gene expression (8, 11).

How does shear stress selectively and differentially regulate such a diverse range of nuclear responses? At least some of these responses appeared to be mediated through regulation of MAP1 kinases (12-16). Members of the MAP kinase family, ERK, JNK (also known as stress-activated protein kinase), and p38 kinase, have been proposed as important signaling components linking extracellular stimuli to cellular responses including cellular growth, death, differentiation, and metabolic regulation (17, 18). Recently, shear stress has been shown to differentially regulate activation of ERK and JNK, and at least some of shear-stimulated gene expressions are regulated by MAP kinases (15, 16).

Shear stress activates ERK in a rapid and transient manner (maximum by 5 min which returns to basal by 30 min shear exposure), whereas JNK activation occurs over a much slower and prolonged time course (requiring at least 30 min and returning to basal levels after 1 day shear exposure) than that of ERK (15). In addition, ERK activation is shear force-dependent (minimum and maximum at 1 and 10 dyn/cm2 shear stress, respectively) whereas that of JNK activity is either "turned off" under no shear condition or "turned on" maximally by even a relatively low shear force (0.5 dyn/cm2) (15). Further studies demonstrated that Galpha i2/tyrosine kinase(s)/Ras and Gbeta /gamma /tyrosine kinase(s)/Ras are upstream regulators of shear-dependent activation of ERK and JNK, respectively (15). How do endothelial cells control activation of specific signaling pathways leading to differential activation of ERK and JNK in response to various shear regimens? We hypothesized that there may be a spatial and/or temporal compartmentalization of signaling complexes in microdomains, which enable an orderly and efficient regulation of signaling cascades in response to shear stress. Cholesterol-enriched compartments such as caveolae and "sphingolipid-cholesterol rafts" (also called as "caveolae-like domains" or "pre-caveolae") are candidate micro-signaling domains (19-22).

Caveolae are non-coated, flask-shaped invaginations of the plasma membrane (50-100 nm in diameter) and are found in most cell types including endothelial cells, fibroblasts, smooth muscle cells and adipocytes (19, 20, 23). However, "flat" caveolae (formed by dynamic clustering of sphingolipids and cholesterol in the cell membrane and caveolae-specific proteins such as caveolin) do exist, although their physiologic significance has not been clearly defined (19-22). Caveolae are found in both the apical and basal plasma membranes and carry out at least two different functions as follows: 1) transport large and small molecules (transcytosis of macromolecules and potocytosis of ions and the vitamin folate), and 2) act as transmembrane signaling microdomains (20-24). Caveolae appear to be formed by self-packaging of "caveolin" along with highly concentrated cholesterol and glycolipids (25-27). In addition, caveolae contain signaling molecules such as Gi2alpha , Src-like kinases, Ras, Raf, and even ERK itself (20, 28-33).

The present study was designed to examine whether cholesterol-sensitive membrane microdomains are involved in the signaling pathways responsible for the differential activation of ERK and JNK in response to shear stress. This study shows evidence that cholesterol or cholesterol-sensitive microdomains in the plasma membrane play a critical role in shear-dependent activation of ERK but not in the JNK pathway.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Cell Culture and Drug Treatment-- BAEC harvested from descending thoracic aortas were maintained (37 °C, 5% CO2) in a growth medium (DMEM (1 g/liter glucose, Life Technologies, Inc.) containing 20% fetal calf serum (FCS, Atlanta Biologicals) without antibiotics) (34). Cells used in this study were between passages 5 and 10. For shear experiments, 1 million cells per glass slide (75 × 38 mm, Fisher) were seeded in growth medium. The next day, the medium was changed to a starvation medium (phenol red-free DMEM containing 0.5% FCS and 25 mM HEPES) and incubated for 18 h. Stock solutions (1 mg/ml each freshly prepared in 95% ethanol) of filipin, digitonin, nystatin, xylazine (Sigma) and up to 0.5% of ethanol as a vehicle control were added to the starvation medium 10 min before subjecting cells to shear stress. Methyl-beta -cyclodextrin (prepared in distilled H2O, Sigma) was added to the starvation medium containing lipoprotein-free FCS (35) and incubated with cells for 60 min. In some studies, 1.3 mM cholesterol (Avanti) was added during the 1-h cyclodextrin treatment to block chelation of cholesterol from cell membrane (36). To test whether the effect of filipin on shear-dependent activation of ERK is reversible, cells were first preincubated with filipin (1 µg/ml) for 10 min, washed in starvation medium, and then incubated in the fresh medium without filipin for up to another hour before subjecting cells to shear stress.

Membrane Integrity Assay Using Calcein AM-- BAEC were incubated with 0.5 µg/ml calcein AM (Molecular Probe) for 30 min at 37° in DMEM, 0.5% FCS. The calcein-loaded cells were washed three times with HEPES-buffered saline (MediaTech) followed by incubation with 0-0.1% Triton X-100 in DMEM containing 0.5% FCS for 10 min at 37 °C. Then, the medium was collected, and cells were harvested in phosphate-buffered saline (PBS). The amount of calcein that leaked out from the cells was determined in a Perkin-Elmer fluorimeter (excitation at 488 nm and emission at 530 nm) as described (37). Aliquots of cell extracts were assayed by DC protein assay (Bio-Rad).

Shear Stress Studies-- The glass slide containing a BAEC monolayer was assembled into a parallel plate shear chamber forming a flow channel (220 µm height × 25 mm width × 62 mm length) between the monolayer and fabricated polycarbonate plate as described (38). Non-pulsatile, laminar shear stress was controlled by changing the flow rate of the starvation medium containing drugs (e.g. filipin or vehicle) delivered to the cells using the constant head flow-loop or a syringe pump (KD Scientific) as described (15, 38).

Preparation of Cell Lysates-- Following shear exposure, cells were washed in ice-cold PBS, scraped in 0.25 ml of lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 1.0 mM vanadate, 1 mM dithiothreitol, 1.0% Triton X-100, and 0.1 mM phenylmethylsulfonyl fluoride), solubilized for 15 min, and centrifuged at 20,000 × g for 15 min to prepare Triton-soluble lysate as described (15). Entire fractionation or solubilization procedures were performed at 4 °C. The protein content of solubilized cell lysates was measured by using a Bio-Rad DC assay kit (Bio-Rad).

Western Blot Analysis of ERK Activation-- Soluble lysates (10 µg each) were resolved by 10% SDS-PAGE, transferred to a polyvinylidene difluoride membrane (Millipore), and probed with antibodies specific to ERK1/2 or phosphorylated forms of ERK1/2 (pERK1/2) (New England Biolabs) as described (15). Goat anti-rabbit IgG-conjugated to alkaline phosphatase was used as a secondary antibody, and the membrane was developed by a chemiluminescent detection method (15).

Immune Complex JNK Assay-- Activity of JNK1 was measured by an immune complex kinase assay using an antibody specific for JNK1 (PharMingen, clone number G151-333) and c-Jun (amino acids 5-89) fused to glutathione S-transferase (GST-c-Jun) as the substrate as described (15). Briefly, Triton-soluble cell lysates (100 µg each) were incubated with JNK1 antibody (0.25 µg) for 1 h at 4 °C, followed by an additional 1-h incubation with protein G-agarose. The immune complex was washed four times in the lysis buffer and twice in buffer A (20 mM HEPES, pH 7.6, 20 mM MgCl2, 20 mM beta -glycerophosphate, 20 mM p-nitrophenyl phosphate, 0.1 mM vanadate, and 2 mM dithiothreitol). The washed immunocomplexes were incubated in 20 µl of buffer A containing GST-c-Jun (5 µg each), 20 µM ATP, and 5 µCi of [gamma -32P]ATP for 20 min at 30 °C. The reaction was terminated by boiling in 5× Laemmli sample buffer, resolved by 10% SDS-PAGE, and electrotransferred to a polyvinylidene difluoride membrane. Autoradiograms were obtained from the dried blot, and radioactivity incorporated into GST-c-Jun was quantitated by cutting and counting each band in a scintillation counter. Quantitative immunoprecipitation of JNK1 was examined by probing the same blot with a polyclonal JNK antibody (39) (kindly provided by Drs. C. C. Franklin and A. S. Kraft at the University of Colorado).

Cytochemical Staining of Cholesterol-- Filipin is fluorescent and has been widely used to localize cellular cholesterol (40). Briefly, BAEC grown on glass slides were washed with ice-cold PBS, fixed with 1% glutaraldehyde on ice for 15 min, rinsed with PBS, and incubated with filipin (50 µg/ml) for 30 min at room temperature. The cells were then washed in PBS followed by distilled H2O, mounted in Slow-fade (Molecular Probe), and examined by epi-fluorescent microscopy (Olympus AH-3) using a UV filter.

Transmission Electron Microscopy (TEM)-- To allow thin sectioning for TEM studies, BAEC were grown on a plastic Mylar sheet (1000A, DuPont) instead of glass slides. Cells were preincubated with vehicle or filipin (5 µg/ml for 0- and 5-min shear groups and 1 µg/ml for 1-h group). Filipin was present during shear. Following shear, cells were fixed for 1 h at 4 °C on ice with 1.6% paraformaldehyde and 3% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3, washed with 0.1 M sodium cacodylate and 3.5% sucrose buffer, pH 7.3, and then post-fixed for 1 h with 1% Palade's OsO4. Cells were stained en bloc with Kellenberger's uranyl acetate, dehydrated, embedded in epoxy resin, and sectioned. Ultra-thin sections were examined by TEM, and 26-67 different random fields (each field containing part of 1 or 2 cells) were photographed. As suggested by Schinitzer et al. (23), only distinctly flask-shaped, non-coated vesicles (50-100 nm in diameter) found on or within 100 nm of both apical and basal plasma membranes were scored as caveolae.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Filipin Does Not Inhibit Shear-dependent Activation of JNK1-- To examine the role of cholesterol in the shear-dependent activation of JNK, BAEC were pretreated with increasing concentrations of filipin or vehicle prior to shear exposure. Treatment of BAEC with filipin did not have any significant effect on static (no shear controls) or shear-dependent activation of JNK (Fig. 1, B and C). In some experiments, cells that were pretreated with filipin were subjected to shear stress in the shear medium containing no filipin. The presence or absence of filipin (1 µg/ml) in the shear medium during a period of 1 h shear had no effect on shear-dependent activation of JNK (data not shown). As shown previously (15), exposure of BAEC to shear stress for 1 h activated JNK1 by 6.5-fold as measured by phosphorylation of GST-c-Jun using JNK1 immunocomplex (Fig. 1B).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1.   Filipin does not inhibit shear-dependent activation of JNK1. BAEC were preincubated for 10 min with filipin (0-5 µg/ml) and further incubated under no flow condition (Static) or exposed to shear stress (5 dyn/cm2) for 1 h. Cell lysates were incubated with a JNK1 antibody (PharMingen) and protein G-agarose, and the immune complex was used to phosphorylate GST-c-Jun (15). Phosphorylated proteins were detected by 10% SDS-PAGE followed by electrotransfer to a polyvinylidene difluoride membrane and autoradiography (B). The same membrane was probed with a rabbit JNK antibody to demonstrate that similar amounts of JNK1 were used in each lane (A). The radioactivity of phosphorylated GST-c-Jun was quantified by cutting and counting each band (C). A representative blot showing HA-JNK1 (~46 kDa) (A) and an autoradiogram of GST-c-Jun phosphorylation (B) are shown. The line graph shown in C is the mean ± S.E. of results obtained from 3 to 6 independent experiments. When cells were preincubated with 5 µg/ml filipin and subsequently exposed to shear stress for 1 h, all cells detached from the glass plate so that JNK activity could not be measured. Filipin treatment did not have any statistically significant effect on the shear-dependent activation of JNK.

Filipin Inhibits Shear Stress-dependent Activation of ERK-- Unlike the case for JNK, pretreatment of cells with filipin (0-1 µg/ml for 10 min) inhibited shear-dependent activation of ERK in a concentration-dependent manner (Fig. 2B and closed circles in C). As shown previously (15), exposure of BAEC to shear stress (10 dyn/cm2) for 5 min stimulated ERK activity by 5-6-fold over the no shear (static) control as measured by Western blot analysis with an antibody specific to phospho-ERK (pERK) (Fig. 2B). Filipin had minor effects reaching up to 2-fold activation of ERK over vehicle control in the static control cells (p = 0.08 to 0.2, paired Student's t tests, see also Figs. 3 and 4).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 2.   Filipin inhibits shear-dependent activation of ERK. BAEC were pretreated with filipin (0 to 1 µg/ml for 10 min) followed by exposure to no shear (static) or shear stress (10 dyn/cm2 for 5 min) and preparation of cell lysates. The lysates (10 µg per lane) were resolved by 10% SDS-PAGE and Western-blotted with antibodies specific to ERK1/2 (A, to demonstrate the equal loading of proteins) or phospho-ERK1/2 (pERK1/2, B, to reveal activation of ERK) (both antibodies from New England Biolabs). Densitometry was performed on both pERK1 and pERK2 bands and showed essentially the same results. Shown in C is the mean ± S.E. of the quantitation of pERK1 bands obtained from three independent experiments.

The Inhibitory Effect of Filipin on Shear Activation of ERK Is Reversible-- Next, we tested whether the inhibitory effect of filipin was reversible. BAEC that were pretreated with filipin (1 µg/ml for 10 min) were washed and incubated in a filipin-free starvation medium for up to 1 h before exposure to shear stress. After 60 min incubation in filipin-free media, shear-stimulated activity of ERK was restored to ~70% of control (filipin-untreated group) (Fig. 3).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   The inhibitory effect of filipin on shear-dependent activation of ERK is reversible. After preincubation of BAEC with or without 1 µg/ml of filipin for 10 min, cells were washed and incubated again in filipin-free medium (DMEM containing 0.5% FCS) for 0, 10, 30, or 60 min (recovery time). Cells were then subjected to shear stress (10dyn/cm2 for 0 or 5 min) and lysed. The lysates were analyzed by Western blot with a pERK1/2 antibody and densitometry as described in Fig. 2. The 1st two lanes and the corresponding bar graph below show the control experiment (static and shear groups without filipin treatment). The line graph shows the percent of recovery (mean ± S.E., n = 3) compared with control (vehicle and shear-treated group) as a function of incubation time in filipin-free medium. Note that the inhibitory effect of filipin on ERK was not observed any more if filipin-treated cells were incubated in a filipin-free medium for 1 h before subjecting cells to shear stress.

Other Cholesterol-binding Reagents Inhibit Shear-stimulated Activity of ERK-- Two other membrane-permeable cholesterol-binding agents, digitonin and nystatin, and a lipid-binding agent, xylazine (as a control), were used to examine the specific functional role of cholesterol in the shear-dependent activation of ERK. Digitonin, a cardiac glycoside (42), inhibited shear-dependent activation of ERK, while raising basal ERK phosphorylation (Fig. 4A). Nystatin, a polyene macrolide antibiotic (43), partially inhibited (by 42%) shear-dependent activation of ERK while having no effect on the basal activity. In contrast, xylazine enhanced the shear-dependent activation of ERK by 45% without any significant effect on the basal activity (Fig. 4A). Next, the effects of these agents on JNK activity were also examined. Unlike ERK activity, digitonin, nystatin, and xylazine did not have any significant effect on shear-activated JNK activity (Fig. 4B). Nystatin and xylazine also had little effect on basal JNK activity, whereas digitonin increased it somewhat (Fig. 4B). At present, the underlying mechanisms for the differential effects of each cholesterol-binding compound on basal ERK activity are not known. Nevertheless, these results demonstrate that removal of cholesterol has specific inhibitory effects on ERK activation, but not JNK, in response to shear stress.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of other cholesterol-binding agents on shear-dependent activation of ERK. BAEC pretreated for 10 min with 5 µg/ml digitonin, nystatin, or xylazine were subjected to shear stress (A, 10 dyn/cm2 for 5 min and B, 5 dyn/cm2 for 1 h). A, phosphorylation of ERK1/2 in the cell lysates was determined by Western blotting using a pERK1/2 antibody and quantitated as described in the legend of Fig. 2. B, JNK activity was determined by using JNK1 immunoprecipitates and GST-c-Jun phosphorylation as described in the legend of Fig. 1. The bar graphs show the mean ± S.E. (n = 3 each).

Permeabilization of Membrane Alone Does Not Lead to Inhibition of Shear-dependent ERK Activation-- Filipin, digitonin, and nystatin can create transmembrane pores and alter membrane permeability. To determine whether the effect of these drugs was due to their nonspecific effect on the membrane permeability, we chose to use a detergent, Triton X-100, to permeabilize the cell membrane in a non-cholesterol-dependent manner. As demonstrated in Fig. 5B, treatment of BAEC with 0.001-0.01% Triton X-100 effectively increased the leakiness of calcein without significantly depleting the total cellular protein level. Under similar conditions, total ERK levels did not change under static conditions (lanes 1-3, Fig. 5A) unless the Triton-treated cells were further subjected to shear stress (lane 7, Fig. 5A). The Triton treatment did not inhibit the shear-dependent activation of ERK, even when there was a significant loss of ERK1/2 (lane 7, Fig. 5A). Although it is relatively minor compared with the robust fold stimulation of ERK by shear stress, basal ERK activity was somewhat increased by Triton permeabilization of cells (Figs. 5A and 6B).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Membrane permeabilization by Triton X-100 does not inhibit shear-dependent ERK activity. A, BAEC that were pretreated with 0-0.01% Triton X-100 for 10 min at 37 °C before subjecting cells to shear stress in fresh shear medium without Triton X-100. Cell lysates were analyzed by Western blotting using antibodies specific to ERK1/2 (top panel) and pERK1/2 (middle panel). The line graph shows the mean ± S.E. (n = 4) obtained from densitometric quantitation of pERK1 bands. B, BAEC that were pre-loaded with calcein AM were incubated with 0-0.1% Triton X-100 as above before collecting the incubation media and cells. Shown are the means ± S.E. (n = 3) of the levels of calcein (bullet ) that remained within the cells after the detergent incubation and total protein (open circle ) measured using the treated cells. The results obtained by measuring the amount of calcein collected in the incubation media were confirmatory (data not shown).

Next, we examined the effect of Triton permeabilization on JNK activity. Similar to the results of ERK, the detergent treatment did not have any effect on JNK activation induced by shear stress while raising basal JNK activity somewhat (Fig. 6C). Again, the effect of Triton on basal JNK activity was relatively minor compared with the robust stimulation of JNK by shear stress (Fig. 6C). Taken together, these results suggested that nonspecific alteration of membrane permeability alone could not account for the inhibitory effect of the cholesterol-binding drugs on shear-dependent ERK activation.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 6.   Sequestration of cholesterol inhibits shear-dependent activation of ERK but not JNK. A, BAEC were pretreated without or with 10 mM methyl-beta -cyclodextrin, 10 mM methyl-beta -cyclodextrin + 1.3 mM cholesterol for 1 h at 37 °C in DMEM containing 0.5% lipoprotein-deficient serum. B, BAEC were first incubated with or without 0.005% Triton X-100 for 10 min at 37 °C, followed by an additional 1 h incubation without or with 5 mM methyl-beta -cyclodextrin in fresh DMEM containing 0.5% lipoprotein-deficient serum. Treated cells were then subjected to shear stress (10 dyn/cm2 for 0 or 5 min) in DMEM containing 0.5% lipoprotein-deficient serum. Western blots for ERK1/2 and pERK1/2 and quantitation were performed as described in Fig. 2. The bar graph shows the mean ± S.E. (n = 3). C, BAEC treated with or without 0.005% Triton X-100 and/or 5 mM methyl-beta -cyclodextrin as described in B were subjected to shear stress (10 dyn/cm2 for 0 or 1 h), and JNK1 activity was determined as described in Fig. 1. The bar graphs show mean ± S.E. (n = 3).

Plasma Membrane Cholesterol Is a Key Component in Shear-dependent Activation of ERK-- To examine whether cholesterol in the plasma membrane plays an essential role in the shear-dependent ERK signaling pathway, a membrane-impermeable cholesterol-binding drug cyclodextrin was used. Cyclodextrin (10 mM) treatment of BAEC prevented the shear-dependent activation of ERK (Fig. 6A). This inhibitory effect was prevented if cholesterol was added back to the incubation medium during the cyclodextrin treatment (Fig. 6A). Time course studies using 5-10 mM cyclodextrin showed that it was necessary to incubate cells with the drug for 1 h (data not shown) suggesting that the cholesterol targeted by cyclodextrin may not initially be in the exofacial plasma membrane where it could be readily accessible by the drug. This slow kinetics could be explained if cholesterol affected by cyclodextrin was present in the cytofacial plasma membrane which translocates slowly to the exofacial side, where it could be removed out of the membrane by binding to cyclodextrin as proposed (44). Treatment of BAEC with 5 mM cyclodextrin also substantially inhibited shear-dependent activation of ERK, although its inhibitory effect was lower than that induced by 10 mM (compare Fig. 6, A and B). However, if cyclodextrin was delivered to the interior of the cell after the cells were Triton-permeabilized, then 5 mM cyclodextrin completely prevented the shear-dependent activation of ERK.

Next, we examined whether the JNK pathway is inhibited by removal of membrane cholesterol using cyclodextrin. Identical to the result obtained with filipin (Fig. 1), cyclodextrin treatment in the absence or presence of Triton X-100 had no significant effect on shear-activated JNK activity (Fig. 6C). Taken together these results shown in Fig. 6 clearly demonstrated that removal of cholesterol by cyclodextrin inhibits shear-dependent activation of ERK but not JNK.

To study the effect of cyclodextrin on plasma membrane cholesterol, the fluorogenic characteristic of filipin (used at 50 µg/ml) was used to cytochemically stain cholesterol and examined by epi-fluorescent microscopy (40). In control cells (Fig. 7A), cholesterol on the cell surface appeared as fine lines, especially visible at borders between cells (marked with arrowheads). Treatment with cyclodextrin eliminated cholesterol staining in the plasma membrane as indicated by arrowheads placed at the border lines between the cells (Fig. 7B). If cholesterol was added during the cyclodextrin treatment, however, the plasma membrane cholesterol was clearly visible (arrowheads) again as in control cells (Fig. 7C). When cells were permeabilized by Triton X-100 and subsequently incubated with cyclodextrin, then the cholesterol staining was no longer visible (Fig. 7D). This complete chelation of cellular cholesterol by cyclodextrin + Triton was not due to the loss of cells as BAEC were still intact (see the phase photomicroscope, Fig. 7E). Moreover, the treatment of BAEC with 0.01% Triton X-100 alone did not alter the cholesterol-staining pattern (data not shown). The results of the cytochemical cholesterol staining studies support that cyclodextrin is membrane-impermeable and its effect is mediated by chelating cholesterol in the plasma membrane. Combined with the results shown in Fig. 6, these findings clearly indicate that cholesterol in the plasma membrane is the target of cyclodextrin and a key element in the shear-dependent ERK signaling pathway.


View larger version (110K):
[in this window]
[in a new window]
 
Fig. 7.   Methyl-beta -cyclodextrin sequesters cell-surface cholesterol. BAEC were pretreated without (A and F) or with 10 mM methyl-beta -cyclodextrin (B), 10 mM methyl-beta -cyclodextrin +1.3 mM cholesterol (C), and 0.005% Triton X-100 followed by 5 mM beta -cyclodextrin (D and E) as described in Fig. 6. After treatment, cells were washed in PBS, fixed in 1% glutaraldehyde, and incubated with PBS (F) or 50 µg/ml filipin (A-E) for 30 min. After washing in PBS, slides were mounted in an anti-fade mounting medium and examined by fluorescent microscopy (× 3,300 magnification) using a UV filter except for E (phase microscopic image of D, × 500 magnification). The surface cholesterol surrounding the cell boundary in control (A) and CD + cholesterol (C)-treated cells are marked with arrowheads. B, arrowheads are used to illustrate the loss of surface cholesterol in cell surface (compare with arrowheads in A and C) by treatment of cells with methyl-beta -cyclodextrin.

Effect of Filipin and Shear Stress on the Number of "Invaginated" Caveolae-- Based on the previous reports in bovine lung microvascular endothelial cells and fibroblasts (19, 23), we speculated that the inhibitory effect of filipin on shear-dependent activation of ERK would be due to loss of "invaginated" caveolae. Consistent with previous reports (23, 45), caveolae were found as single as well as clusters of non-coated vesicles (see arrowheads in Fig. 8A) on or near the apical and basal plasma membranes of BAEC. There were ~0.15 caveolae/µm in control cells as quantified by counting the number of "invaginated" caveolae seen by TEM using the morphological criteria suggested by Schnitzer and colleagues (23, 45). To our surprise, however, filipin treatment (up to 5 µg/ml for up to 1 h at 37 °C) did not reduce the number of invaginated caveolae in static controls and shear-exposed groups (Fig. 8B). On the other hand, exposure of BAEC to shear stress for 1 h increased invaginated caveolae by 3-fold (Fig. 8B).


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 8.   Filipin does not decrease the number of invaginated caveolae, but shear stress increases their numbers in BAEC. BAEC were preincubated with vehicle or filipin (5 µg/ml for 0- and 5-min shear groups and 1 µg/ml for 1-h group). Following shear, cells were thin sectioned and examined by electron microscopy as described under "Materials and Methods." Two to four independently prepared endothelial monolayers were used to photograph 26-62 different randomly chosen fields from each group. Only distinctly invaginated vesicles (50-100 nm diameter) found within 100 nm of both apical and basal plasma membranes were counted. Shown in A are examples of caveolae (arrowheads) obtained from control BAEC, and shown in B are average caveolae numbers per µm ± S.E. (*, p < 0.05; **, p < 0.02; ***, p < 0.001 as determined by Student's t tests). Note the 3-fold increase in caveolae numbers after 60 min shear stress over static control. Some portions of monolayers that were saved before fixing them for EM studies were used for Western blot analysis with a pERK1/2 antibody and confirmed that filipin treatment inhibited shear activation of ERK as shown in Fig. 2.


    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Early atherosclerotic plaques tend to develop in curved and branched arterial regions, which are associated with disturbed and/or low shear stress conditions, whereas areas exposed to stable and high shear forces are relatively well protected (46, 47). Similarly, various shear regimens (laminar, turbulent, step, and gradual changes) induce different endothelial responses including gene expression, NO release, and activation of MAP kinases over different time courses (1, 3, 9, 15, 38, 48). How do endothelial cells recognize the differences in shear stress and respond accordingly? The results presented in this study suggest that endothelial cells contain cholesterol-sensitive structures and/or signaling modules that may render signaling specificity leading to selective activation of ERK without affecting that of JNK pathway in response to shear stress.

Chelation of Cholesterol Prevents Shear-dependent Activation of ERK but Not JNK-- In this study, we presented several lines of evidence supporting the concept that the removal of cholesterol in the plasma membrane results in selective inhibition of the shear-sensitive ERK pathway. First, filipin treatment only blocked activation of ERK, but not JNK, in response to shear stress (Figs. 1 and 2). Second, other membrane-permeable cholesterol-binding drugs (digitonin and nystatin), but not a lipid-binding drug (xylazine), inhibited activation of ERK, but not JNK, by shear stress (Fig. 4). Third, the specific nature of these drugs was also supported by demonstrating the reversibility of filipin effect (Fig. 3). Fourth, the lack of Triton's ability to inhibit the shear-sensitive ERK activation makes it unlikely that the inhibitory effects of filipin, digitonin, and nystatin could be solely attributed to their characteristic as detergents (Fig. 5). Finally, cyclodextrin, a cell-impermeant agent that sequesters plasma membrane cholesterol by inducing its efflux, selectively inhibited the shear-dependent activation of ERK but not JNK. Moreover, the inhibitory effect of cyclodextrin was reversed by adding exogenous cholesterol (Figs. 6 and 7).

Plasma Membrane Cholesterol Is Essential to the Shear-dependent Activation of ERK-- It has been shown that ~85% of free cholesterol is present within the plasma membrane, and the majority (75-97%) of these cholesterol molecules are found in the cytofacial leaflet in mammalian cells (44, 49). Fielding and Fielding (44) proposed a classification of the cellular free cholesterol into three pools as follows: (a) the "fast pool" present in the exofacial plasma membrane, (b) an "intermediate pool" representing the cytofacial free cholesterol in transit toward the exofacial plasma membrane, and (c) a "slow pool" that is found intracellularly. During our study, we observed that the inhibitory effects of cyclodextrin (5 to 10 mM) were observed only after a relatively long incubation period (30-60 min). The exofacial cholesterol (3-25% of total cholesterol in the plasma membrane) is directly accessible by cyclodextrin and is expected to be removed quickly (fast pool) (44, 50). However, we have not been able to block the shear-sensitive ERK by less than 30 min cyclodextrin treatment (data not shown) suggesting that the exofacial cholesterol is not likely to be a key component in this shear-signaling pathway. It seems more likely, however, that the slow time course of cyclodextrin action could be explained by the slow movement of the cytofacial cholesterol to the exofacial plasma membrane. Therefore, the cholesterol or cholesterol-enriched compartments present in the cytofacial plasma membrane could be responsible for the regulation of shear-sensitive ERK activation.

A specific role for cholesterol in the proper functioning of receptors and other membrane proteins, including G-proteins, has been reported. For example, receptors for 5-methyltetrahydrofolate, rhodopsin, oxytocin, cholecystokinin, transferrin, and acetylcholine have all been shown to require cholesterol for optimal functioning (36, 51-54). As early as 1975, Limbird and Lefkowitz (55) showed that the proper coupling of beta -adrenergic receptors to adenylate cyclase was uncoupled by removing cholesterol. The role of cholesterol could also be to regulate membrane fluidity or rigidity (36). Since cholesterol directly binds to caveolin-1, cholesterol could directly influence the function of caveolin-1, which interacts and regulates many signaling molecules including G-proteins, Src, and Ras (20, 27, 56).

One question raised by the present study is whether cholesterol-sensitive structures such as caveolae or sphingolipid-cholesterol rafts play a role in the shear-dependent activation of ERK. In support of the role for these membrane domains, Anderson and co-workers (32) have shown that ERK is activated in caveolae in intact cells. In addition, they demonstrated that isolated caveolae contain the functionally intact, signaling module that was able to stimulate ERK upon platelet-derived growth factor addition (57). The results presented in our current study are also consistent with a role for the cholesterol-sensitive domains in activation of ERK by shear stress.

Number of Invaginated Caveolae Is Not a Critical Factor in ERK Activation by Shear Stress-- Exposure of BAEC to shear for 1 h increased the number of invaginated caveolae by 3-fold (Fig. 8). This result suggests that the presence or absence of blood flow (shear stress) may be a major determinant of the density of invaginated caveolae. Although the number of invaginated caveolae is dynamically controlled by shear stress, it does not seem to play a critical role in shear-dependent activation of ERK (Fig. 8). Treatment of fibroblasts or bovine lung microvascular endothelial cells with filipin has been shown to decrease the number of invaginated caveolae (19, 23). However, our study using endothelial cells of aortic origin (BAEC) show that the effect of filipin on ERK activation by shear stress is not due to a decrease in the number of invaginated caveolae (Fig. 8). The reasons for these discrepancies are not clear at this time. However, it is well known that endothelial cells of different vascular origins differ in function and morphology including the number of caveolae (45, 58, 59). Therefore, it is not surprising to find that the secondary effect of the cholesterol-binding drug, filipin, on the number of invaginated caveolae is dependent upon cell types. The current study indicates that cholesterol-binding drugs can inhibit cellular functions (such as ERK activation) without apparent morphological changes in BAEC. Since cholesterol binds directly to caveolin-1 (27, 56), a potential mechanism of filipin action may include the disruption of cholesterol-caveolin interaction.

Physiological Implications of Membrane Cholesterol in Differential Regulation of MAP Kinases-- Previously, we showed (15) that shear stress rapidly and transiently activates ERK in shear force-dependent manner (maximum activation by 10 dyn/cm2 for 5 min), whereas JNK is activated over a slower time course in a low threshold-dependent manner (maximum activation by shear force as low as 0.5 dyn/cm2 for 1 h). This differential activation of ERK and JNK involves two separate signaling pathways that depend on two different heterotrimeric G-proteins and some common signaling molecules. For example, we showed that shear stress stimulates ERK by mechanisms involving Gi2alpha , tyrosine kinase(s), and Ras, whereas JNK activation by shear stress involves non-pertussis toxin-sensitive Galpha , Gbeta /gamma , tyrosine kinase(s), and Ras (15). More recently, we found that the G-protein-dependent phosphatidylinositol 3-kinase gamma  is rapidly and transiently activated by shear stress (maximum activation by 15 s which returns to basal by 1 min shear exposure) and that phosphatidylinositol 3-kinase gamma  selectively mediates shear activation of JNK but not ERK (60). In contrast, Shyy, Chien, and their colleagues (14, 61) have shown that focal adhesion kinase (FAK) and Src are upstream signaling molecules required to activate both ERK and JNK by shear stress in BAEC, although the role of FAK in shear activation of ERK appears to be cell type-specific (62).

Taken together, accumulating evidence strongly indicates that Gi2alpha , PKCepsilon , Src, FAK, and Ras are upstream signaling molecules for the shear activation of ERK (13-15, 61) at least in BAEC. In contrast, a pertussis toxin-insensitive heterotrimeric Galpha , beta /gamma , phosphatidylinositol 3-kinase gamma , Src, FAK, and Ras regulate the shear-dependent activation of JNK (14, 15, 60, 61). The molecular basis for the differential activation of ERK and JNK by involving two different G-proteins as well as the common signaling molecules (Src, FAK, and Ras) is then likely to require a spatial and/or temporal compartmentalization of signaling modules/molecules. Cholesterol-sensitive microdomains in the plasma membrane, such as caveolae-like domains, provide a plausible means of spatial and/or temporal sequestration of signaling units for the differential activation of MAP kinases. Determining the underlying mechanisms and morphologic structures by which cholesterol or cholesterol-sensitive microdomains segregate signaling molecules and render selective regulation of MAP kinases will be an important area of future investigation.

    ACKNOWLEDGEMENTS

We thank Drs. A. Kraft and C. Franklin for a GST-c-Jun plasmid and a rabbit JNK antibody and Dr. V. Darley-Usmar for critically reading this manuscript.

    FOOTNOTES

* This work was supported by a National Institutes of Health First Award HL53601 and an American Heart Association Grant-in-aid AL-G-960035 (to H. J.), National Institutes of Health Grant DK52483 (to D.R.A.), and National Institutes of Health FIRST Award GM-50443, a grant from the G. Harold and Leila Y. Mathers Charitable Foundation, and a Scholarship in the Medical Sciences from the Charles E. Culpeper Foundation (to M. P. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

parallel To whom correspondence should be addressed: University of Alabama at Birmingham, Division of Molecular and Cellular Pathology, Dept. of Pathology, G019C Volker Hall, Birmingham, AL 35294. Tel.: 205-975-8041; Fax: 205-934-1775; E-mail: Jo{at}path.uab.edu.

The abbreviations used are: MAP kinase, mitogen-activated protein kinase; BAEC, bovine aortic endothelial cells; ERK, extracellular signal regulated kinase; GST-c-Jun, c-Jun (amino acids 5-89) fused to glutathione S-transferase; JNK, NH2-terminal Jun kinase; FCS, fetal calf serum; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; FAK, focal adhesion kinase; TEM, transmission electron microscopy.
    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Davies, P. F. (1995) Physiol. Rev. 75, 519-560[Abstract/Free Full Text]
  2. Diamond, S. L., Eskin, S. G., and McIntire, L. V. (1989) Science 243, 1483-1485[Abstract/Free Full Text]
  3. Malek, A. M., Greene, A. L., and Izumo, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5999-6003[Abstract/Free Full Text]
  4. Nishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S. P., Uematsu, M., Nerem, R. M., Alexander, R. W., and Murphy, T. J. (1992) J. Clin. Invest. 90, 2092-2096
  5. Malek, A. M., Gibbons, G. H., Dzau, V. J., and Izumo, S. (1993) J. Clin. Invest. 92, 2013-2021
  6. Resnick, N., Collins, T., Atkinson, W., Bonthron, D. T., Dewey, C. F., Jr., and Gimbrone, M. A., Jr. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4591-4595[Abstract/Free Full Text]
  7. Morita, T., Yoshizumi, M., Kurihara, H., Maemura, K., Nagai, R., and Yazaki, Y. (1993) Biochem. Biophys. Res. Commun. 197, 256-262[CrossRef][Medline] [Order article via Infotrieve]
  8. Khachigian, L. M., Resnick, N., Gimbrone, M. A. J., and Collins, T. (1995) J. Clin. Invest. 96, 1169-1175
  9. Topper, J. N., Cai, J., Falb, D., and Gimbrone, M. A., Jr. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10417-10422[Abstract/Free Full Text]
  10. Lin, M. C., Almus-Jacobs, F., Chen, H. H., Parry, G. C., Mackman, N., Shyy, J. Y., and Chien, S. (1997) J. Clin. Invest. 99, 737-744[Medline] [Order article via Infotrieve]
  11. Hsieh, H. J., Li, N. Q., and Frangos, J. A. (1993) J. Cell. Physiol. 154, 143-151[CrossRef][Medline] [Order article via Infotrieve]
  12. Tseng, H., Peterson, T. E., and Berk, B. C. (1995) Circ. Res. 77, 869-878[Abstract/Free Full Text]
  13. Traub, O., Monia, B. P., Dean, N. M., and Berk, B. C. (1997) J. Biol. Chem. 272, 31251-31257[Abstract/Free Full Text]
  14. Li, S., Kim, M., Hu, Y.-L., Jalali, S., Schlaepfer, D. D., Hunter, T., Chien, S., and Shyy, J. Y.-J. (1997) J. Biol. Chem. 272, 30455-30462[Abstract/Free Full Text]
  15. Jo, H., Sipos, K., Go, Y.-M., Law, R., Rong, J., and McDonald, J. M. (1997) J. Biol. Chem. 272, 1395-1401[Abstract/Free Full Text]
  16. Li, Y. S., Shyy, J. Y. J., Li, S., Lee, J. D., Su, B., Karin, M., and Chien, S. (1996) Mol. Cell. Biol. 16, 5947-5954[Abstract]
  17. Cobb, M. H., and Goldsmith, E. J. (1995) J. Biol. Chem. 270, 14843-14846[Free Full Text]
  18. Karin, M. (1994) Curr. Opin. Cell Biol. 6, 415-424[CrossRef][Medline] [Order article via Infotrieve]
  19. Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y. S., Glenney, J. R., and Anderson, R. G. (1992) Cell 68, 673-682[CrossRef][Medline] [Order article via Infotrieve]
  20. Okamoto, T., Schlegel, A., Scherer, P. E., and Lisanti, M. P. (1998) J. Biol. Chem. 273, 5419-5422[Free Full Text]
  21. Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve]
  22. Harder, T., and Simons, K. (1997) Curr. Opin. Cell Biol. 9, 534-542[CrossRef][Medline] [Order article via Infotrieve]
  23. Schnitzer, J. E., Oh, P., Pinney, E., and Allard, J. (1994) J. Cell Biol. 127, 1217-1232[Abstract/Free Full Text]
  24. Smart, E. J., Foster, D. C., Ying, Y. S., Kamen, B. A., and Anderson, R. G. (1994) J. Cell Biol. 124, 307-313[Abstract/Free Full Text]
  25. Song, K. S., Tang, Z., Li, S., and Lisanti, M. P. (1997) J. Biol. Chem. 272, 4398-4403[Abstract/Free Full Text]
  26. Fra, A. M., Masserini, M., Palestini, P., Sonnino, S., and Simons, K. (1995) FEBS Lett. 375, 11-14[CrossRef][Medline] [Order article via Infotrieve]
  27. Li, S., Song, K. S., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 568-573[Abstract/Free Full Text]
  28. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., and Lisanti, M. P. (1995) J. Biol. Chem. 270, 15693-15701[Abstract/Free Full Text]
  29. Li, S., Couet, J., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 29182-29190[Abstract/Free Full Text]
  30. Song, K. S., Li, S. W., Okamoto, T., Quilliam, L. A., Sargiacomo, M., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 9690-9697[Abstract/Free Full Text]
  31. Mineo, C., James, G. L., Smart, E. J., and Anderson, R. G. W. (1996) J. Biol. Chem. 271, 11930-11935[Abstract/Free Full Text]
  32. Liu, P., Ying, Y., and Anderson, R. G. (1996) Proc. Natl. Acad. Sci. U. S. A. 94, 13666-13670[Abstract/Free Full Text]
  33. Liu, J., Oh, P., Horner, T., Rogers, R. A., and Schnitzer, J. E. (1997) J. Biol. Chem. 272, 7211-7222[Abstract/Free Full Text]
  34. Jo, H., Dull, R. O., Hollis, T. M., and Tarbell, J. M. (1991) Am. J. Physiol. 260, H1992-H1996[Abstract/Free Full Text]
  35. Goldstein, J. L., Basu, S. K., and Brown, M. S. (1983) Methods Enzymol. 98, 241-260[Medline] [Order article via Infotrieve]
  36. Gimpl, G., Burger, K., and Fahrenholz, F. (1997) Biochemistry 36, 10959-10974[CrossRef][Medline] [Order article via Infotrieve]
  37. Bischof, J. C., Padanilam, J., Holmes, W. H., Ezzell, R. M., Lee, R. C., Tompkins, R. C., Yarmush, M. L., and Toner, M. (1995) Biophys. J. 68, 2608-2614[Medline] [Order article via Infotrieve]
  38. Kuchan, M. J., Jo, H., and Frangos, J. A. (1994) Am. J. Physiol. 267, C753-C758[Abstract/Free Full Text]
  39. Franklin, C. C., and Kraft, A. S. (1997) J. Biol. Chem. 272, 16917-16923[Abstract/Free Full Text]
  40. Porn, M. I., and Slotte, J. P. (1995) Biochem. J. 308, 269-274
  41. Davies, P. F., Robotewskyj, A., and Griem, M. L. (1994) J. Clin. Invest. 93, 2031-2038
  42. Elias, P. M., Goerke, J., Friend, D. S., and Brown, B. E. (1978) J. Cell Biol. 78, 577-596[Abstract/Free Full Text]
  43. Bolard, J. (1986) Biochim. Biophys. Acta 864, 257-304[Medline] [Order article via Infotrieve]
  44. Fielding, C. J., and Fielding, P. E. (1997) J. Lipid Res. 38, 1503-1521[Abstract]
  45. Schnitzer, J. E., Siflinger-Birnboim, A., Del Vecchio, P. J., and Malik, A. B. (1994) Biochem. Biophys. Res. Commun. 199, 11-19[CrossRef][Medline] [Order article via Infotrieve]
  46. Zarins, C. K., Giddens, D. P., Bharadvaj, B. K., Sottiurai, V. S., Mabon, R. F., and Glagov, S. (1983) Circ. Res. 53, 502-514[Abstract/Free Full Text]
  47. Ku, D. N., Giddens, D. P., Zarins, C. K., and Glagov, S. (1985) Arteriosclerosis 5, 293-302[Abstract/Free Full Text]
  48. Frangos, J. A., Huang, T. Y., and Clark, C. B. (1996) Biochem. Biophys. Res. Commun. 224, 660-665[CrossRef][Medline] [Order article via Infotrieve]
  49. Schroeder, F., and Nemecz, G. (1990) in Advances in Cholesterol Research (Esfahani, M., and Swaney, J., eds), pp. 47-87, Telford Press, Caldwell, NJ
  50. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P. C., Stoudt, G. W., Johnson, W. J., Philips, M. C., and Rothblat, G. H. (1996) J. Biol. Chem. 271, 16026-16034[Abstract/Free Full Text]
  51. Rothberg, K. G., Ying, Y.-S., Kamen, B. A., and Anderson, R. G. W. (1990) J. Cell Biol. 111, 2931-2938[Abstract/Free Full Text]
  52. Albert, A. D., Young, J. E., and Yeagle, P. L. (1996) Biochim. Biophys. Acta 1285, 47-55[Medline] [Order article via Infotrieve]
  53. Nunez, M. T., and Glass, J. (1982) Biochemistry 21, 4139-4143[CrossRef][Medline] [Order article via Infotrieve]
  54. Narayanaswami, V., and McNamee, M. G. (1993) Biochemistry 32, 12420-12427[CrossRef][Medline] [Order article via Infotrieve]
  55. Limbird, L. E., and Lefkowitz, R. J. (1975) Mol. Pharmacol. 12, 559-567[Abstract/Free Full Text]
  56. Murata, M., Peranen, J., Schriber, R., Weiland, F., Kurzchalia, T., and Simons, K. (1995) Proc. Natl. Acad. Sci., U. S. A. 92, 10339-10343[Abstract/Free Full Text]
  57. Liu, P., Ying, Y., and Anderson, R. G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 13666-13670
  58. Risau, W. (1995) FASEB J. 9, 926-933[Abstract]
  59. Augustin, H. G., Kozian, D. H., and Johnson, R. C. (1994) BioEssays 16, 901-906[CrossRef][Medline] [Order article via Infotrieve]
  60. Go, Y. M., Park, H., Maland, M. C., Darley-Usmar, V. M., Stoyanov, B., Wetzker, R., and Jo, H. (1998) Am. J. Physiol. 44, H1898-H1904
  61. Jalali, S., Li, Y. S., Sotoudeh, M., Yuan, S., Li, S., Chien, S., and Shyy, J. Y. (1998) Arterioscler. Thromb. Vasc. Biol. 18, 227-234[Abstract/Free Full Text]
  62. Ishida, T., Peterson, T. E., Kovach, N. L., and Berk, B. C. (1996) Circ. Res. 79, 310-316[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Ali, M. Zakkar, K. Karu, E. A. Lidington, S. S. Hamdulay, J. J. Boyle, M. Zloh, A. Bauer, D. O. Haskard, P. C. Evans, et al.
Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow
J. Biol. Chem., July 10, 2009; 284(28): 18882 - 18892.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J.-L. Balligand, O. Feron, and C. Dessy
eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues
Physiol Rev, April 1, 2009; 89(2): 481 - 534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Khan, E. S. Muise, P. Iyengar, Z. V. Wang, M. Chandalia, N. Abate, B. B. Zhang, P. Bonaldo, S. Chua, and P. E. Scherer
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
Mol. Cell. Biol., March 15, 2009; 29(6): 1575 - 1591.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kim, J. Park, S. Choi, S.-G. Chi, A. L. Mowbray, H. Jo, and H. Park
X-Linked Inhibitor of Apoptosis Protein Is an Important Regulator of Vascular Endothelial Growth Factor-Dependent Bovine Aortic Endothelial Cell Survival
Circ. Res., April 25, 2008; 102(8): 896 - 904.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yamamoto, N. Shimizu, S. Obi, S. Kumagaya, Y. Taketani, A. Kamiya, and J. Ando
Involvement of cell surface ATP synthase in flow-induced ATP release by vascular endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1646 - H1653.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Peng, D. Wu, A. J. Ingram, B. Zhang, B. Gao, and J. C. Krepinsky
RhoA Activation in Mesangial Cells by Mechanical Strain Depends on Caveolae and Caveolin-1 Interaction
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 189 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Rubin, T. C. Murphy, J. Rahnert, H. Song, M. S. Nanes, E. M. Greenfield, H. Jo, and X. Fan
Mechanical Inhibition of RANKL Expression Is Regulated by H-Ras-GTPase
J. Biol. Chem., January 20, 2006; 281(3): 1412 - 1418.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. C. Bellott, K. C. Patel, and T. J. Burkholder
Reduction of caveolin-3 expression does not inhibit stretch-induced phosphorylation of ERK2 in skeletal muscle myotubes
J Appl Physiol, April 1, 2005; 98(4): 1554 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. G. Sedding, J. Hermsen, U. Seay, O. Eickelberg, W. Kummer, C. Schwencke, R. H. Strasser, H. Tillmanns, and R. C. Braun-Dullaeus
Caveolin-1 Facilitates Mechanosensitive Protein Kinase B (Akt) Signaling In Vitro and In Vivo
Circ. Res., April 1, 2005; 96(6): 635 - 642.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Mandal, A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao
Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol
Blood, January 1, 2005; 105(1): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. O. Lungu, Z.-G. Jin, H. Yamawaki, T. Tanimoto, C. Wong, and B. C. Berk
Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae
J. Biol. Chem., November 19, 2004; 279(47): 48794 - 48800.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Podar, R. Shringarpure, Y.-T. Tai, M. Simoncini, M. Sattler, K. Ishitsuka, P. G. Richardson, T. Hideshima, D. Chauhan, and K. C. Anderson
Caveolin-1 Is Required for Vascular Endothelial Growth Factor-Triggered Multiple Myeloma Cell Migration and Is Targeted by Bortezomib
Cancer Res., October 15, 2004; 64(20): 7500 - 7506.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. S. Doan, D. A. Windmiller, and D. W. H. Riches
Differential Regulation of TNF-R1 Signaling: Lipid Raft Dependency of p42mapk/erk2 Activation, but Not NF-{kappa}B Activation
J. Immunol., June 15, 2004; 172(12): 7654 - 7660.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-P. Gratton, P. Bernatchez, and W. C. Sessa
Caveolae and Caveolins in the Cardiovascular System
Circ. Res., June 11, 2004; 94(11): 1408 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. T. Ferraro, M. Daneshmand, R. Bizios, and V. Rizzo
Depletion of plasma membrane cholesterol dampens hydrostatic pressure and shear stress-induced mechanotransduction pathways in osteoblast cultures
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C831 - C839.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. VanderLaan, C. A. Reardon, and G. S. Getz
Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 12 - 22.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Rizzo, C. Morton, N. DePaola, J. E. Schnitzer, and P. F. Davies
Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1720 - H1729.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Kifor, I. Kifor, F. D. Moore Jr., R. R. Butters Jr., T. Cantor, P. Gao, and E. M. Brown
Decreased Expression of Caveolin-1 and Altered Regulation of Mitogen-Activated Protein Kinase in Cultured Bovine Parathyroid Cells and Human Parathyroid Adenomas
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4455 - 4464.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zeidan, J. Broman, P. Hellstrand, and K. Sward
Cholesterol Dependence of Vascular ERK1/2 Activation and Growth in Response to Stretch: Role of Endothelin-1
Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1528 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. L. Boyd, H. Park, H. Yi, Y. C. Boo, G. P. Sorescu, M. Sykes, and H. Jo
Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1113 - H1122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Ogata
Increase in epidermal growth factor receptor protein induced in osteoblastic cells after exposure to flow of culture media
Am J Physiol Cell Physiol, August 1, 2003; 285(2): C425 - C432.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Ma, Y. Z. Huang, G. M. Pitcher, J. G. Valtschanoff, Y. H. Ma, L. Y. Feng, B. Lu, W. C. Xiong, M. W. Salter, R. J. Weinberg, et al.
Ligand-Dependent Recruitment of the ErbB4 Signaling Complex into Neuronal Lipid Rafts
J. Neurosci., April 15, 2003; 23(8): 3164 - 3175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Podar, Y.-T. Tai, C. E. Cole, T. Hideshima, M. Sattler, A. Hamblin, N. Mitsiades, R. L. Schlossman, F. E. Davies, G. J. Morgan, et al.
Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells
J. Biol. Chem., February 14, 2003; 278(8): 5794 - 5801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Czarny, J. Liu, P. Oh, and J. E. Schnitzer
Transient Mechanoactivation of Neutral Sphingomyelinase in Caveolae to Generate Ceramide
J. Biol. Chem., February 7, 2003; 278(7): 4424 - 4430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Baqui, D. Botero, B. Gereben, C. Curcio, J. W. Harney, D. Salvatore, K. Sorimachi, P. R. Larsen, and A. C. Bianco
Human Type 3 Iodothyronine Selenodeiodinase Is Located in the Plasma Membrane and Undergoes Rapid Internalization to Endosomes
J. Biol. Chem., January 3, 2003; 278(2): 1206 - 1211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chen and M. D. Resh
Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor
J. Biol. Chem., December 13, 2002; 277(51): 49631 - 49637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ushio-Fukai, L. Hilenski, N. Santanam, P. L. Becker, Y. Ma, K. K. Griendling, and R. W. Alexander
Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells. ROLE OF CHOLESTEROL-RICH MICRODOMAINS AND FOCAL ADHESIONS IN ANGIOTENSIN II SIGNALING
J. Biol. Chem., December 14, 2001; 276(51): 48269 - 48275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S.-S. Wang, D. L. Rymer, and T. A. Good
Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of beta -Amyloid Peptides
J. Biol. Chem., November 2, 2001; 276(45): 42027 - 42034.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Wei, A. B. Al-Mehdi, and A. B. Fisher
Signaling pathway for nitric oxide generation with simulated ischemia in flow-adapted endothelial cells
Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2226 - H2232.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y.-M. Go, Y. C. Boo, H. Park, M. C. Maland, R. Patel, K. A. Pritchard Jr., Y. Fujio, K. Walsh, V. Darley-Usmar, and H. Jo
Protein kinase B/Akt activates c-Jun NH2-terminal kinase by increasing NO production in response to shear stress
J Appl Physiol, October 1, 2001; 91(4): 1574 - 1581.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Nilius and G. Droogmans
Ion Channels and Their Functional Role in Vascular Endothelium
Physiol Rev, October 1, 2001; 81(4): 1415 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Darblade, D. Caillaud, M. Poirot, M.-J. Fouque, J.-C. Thiers, J. Rami, F. Bayard, and J.-F. Arnal
Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta
Cardiovasc Res, June 1, 2001; 50(3): 566 - 576.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Westmuckett, C. Lupu, S. Roquefeuil, T. Krausz, V. V. Kakkar, and F. Lupu
Fluid Flow Induces Upregulation of Synthesis and Release of Tissue Factor Pathway Inhibitor In Vitro
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2474 - 2482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Park, Y.-M. Go, R. Darji, J.-W. Choi, M. P. Lisanti, M. C. Maland, and H. Jo
Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase
Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1285 - H1293.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. M. Morganelli, S. M. Kennedy, and T. I. Mitchell
Differential effects of interferon-{gamma} on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fc{gamma} receptors
J. Lipid Res., March 1, 2000; 41(3): 405 - 415.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
M Kajimura and C C Michel
Flow modulates the transport of K+ through the walls of single perfused mesenteric venules in anaesthetised rats
J. Physiol., December 15, 1999; 521(3): 665 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. U. Katagiri, T. Mori, H. Nakajima, C. Katagiri, T. Taguchi, T. Takeda, N. Kiyokawa, and J. Fujimoto
Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains
J. Biol. Chem., December 3, 1999; 274(49): 35278 - 35282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-M. Go, R. P. Patel, M. C. Maland, H. Park, J. S. Beckman, V. M. Darley-Usmar, and H. Jo
Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH2-terminal kinase
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1647 - H1653.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Corvera, C. DiBonaventura, and H. S. Shpetner
Cell Confluence-dependent Remodeling of Endothelial Membranes Mediated by Cholesterol
J. Biol. Chem., September 29, 2000; 275(40): 31414 - 31421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Fringer and F. Grinnell
Fibroblast Quiescence in Floating or Released Collagen Matrices. CONTRIBUTION OF THE ERK SIGNALING PATHWAY AND ACTIN CYTOSKELETAL ORGANIZATION
J. Biol. Chem., August 10, 2001; 276(33): 31047 - 31052.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, H.
Right arrow Articles by Jo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, H.
Right arrow Articles by Jo, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement